Achilles Therapeutics announced the resignation of three members from its Board of Directors, effective December 31, 2024, as part of a planned reduction in board size. The resignations of Julie O ...

Achilles Therapeutics (ACHL) announced that it has transferred the commercial license of data and samples from the TRACERx Non-Small Cell Lung Cancer study to AstraZeneca (AZN). TRACERx ...

Achilles Therapeutics plc has announced the transfer of data and samples from its TRACERx Non-Small Cell Lung Cancer study and its Material Acquisition Platform (MAP) to AstraZeneca for a total ...

LONDON, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL) today announced that on November 15, 2024, the Listing Qualifications department of the Nasdaq Stock Market LLC ...

Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) was the target of a significant growth in short interest in the month of December.As of December 31st, there was short interest ...